Vagi-Hex
Vagi-Hex is a medicine authorised by Swissmedic under authorisation number 50001. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 February 1994 and the authorisation is valid without a time limit. ATC code G01AX16 places the medicine in the group Gynecological anti-infectives and antiseptics.
| Authorisation number | 50001 |
|---|---|
| Name | Vagi-Hex |
| Full name | Vagi-Hex, Vaginaltabletten |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G01AX16 |
| First authorisation | 28 February 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vagi-Hex, Vaginaltabletten | B | 28 February 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 12 | Tablette(n) | G01AX16 | 09.03.0. | B |
| 2 | 24 | Tablette(n) | G01AX16 | 09.03.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Vagi-Hex authorised in Switzerland?
Yes. Vagi-Hex is authorised by Swissmedic under authorisation number 50001, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Vagi-Hex have?
Vagi-Hex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Vagi-Hex?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.